Related Experiment Video
Updated: Aug 21, 2026

Visualization of Inflammatory Caspases Induced Proximity in Human Monocyte-Derived Macrophages
Published on: April 6, 2022
Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple
Wen-Xin Huang1, Ping Huang, Jan Hillert
1Division of Neurology, Karolinska Institute, Huddinge University Hospital, Huddinge, Sweden.
Abstract:
Multiple sclerosis (MS) is supposedly a T-cell mediated autoimmune disorder of the central nervous system. Cytokines and other molecules involved in the regulation of apoptosis are thought to be of importance for the pathogenesis of MS. In this study, the mRNA levels of interleukin 18 (IL-18), IL-1beta and their processing enzyme caspase-1 were quantified by a competitive RT-PCR method in unstimulated peripheral blood mononuclear cells (PBMCs) in MS patients never treated with disease modifying drugs. Western blot was used to support the expression pattern at the protein level. We found that the expression of caspase-1 and IL-18 was significantly increased in MS patients compared with healthy controls. Analysis of clinical subgroups revealed that caspase-1 was increased in all subgroups, whereas IL-18 was upregulated in chronic progression (P=0.001) and relapsing MS patients in remission (P=0.002) but not significantly during relapses (P=0.12). mRNA levels of IL-1beta were not significantly altered in MS except for a possible decrease in chronic progression (P=0.03). An increased IL-18 expression, potentially augmented at the mature protein level, may indicate a pathway worth considering in future therapeutic strategies in MS.
Insights
This study found increased levels of caspase-1 and interleukin-18 (IL-18) in multiple sclerosis (MS) patients, suggesting a potential role for these molecules in MS pathogenesis and future therapies.
Area of Science:
- Neuroimmunology
- Immunology
- Molecular Biology
Background:
- Multiple sclerosis (MS) is an autoimmune disorder affecting the central nervous system, with T-cells and apoptosis-regulating molecules implicated in its pathogenesis.
- The role of specific cytokines, such as interleukin-18 (IL-18) and interleukin-1beta (IL-1beta), and their processing enzyme caspase-1 in MS is not fully elucidated.
Purpose of the Study:
- To quantify the mRNA and protein expression levels of IL-18, IL-1beta, and caspase-1 in peripheral blood mononuclear cells (PBMCs) of untreated multiple sclerosis patients.
- To investigate the correlation between the expression of these molecules and different clinical subtypes of MS.
Main Methods:
- Competitive reverse transcription-polymerase chain reaction (RT-PCR) was used to measure mRNA levels of IL-18, IL-1beta, and caspase-1.
- Western blot analysis was employed to validate protein expression patterns.
- Peripheral blood mononuclear cells (PBMCs) were analyzed from patients with multiple sclerosis and healthy controls.
Main Results:
- Significantly increased mRNA expression of caspase-1 and IL-18 was observed in multiple sclerosis patients compared to healthy controls.
- Caspase-1 expression was elevated across all MS clinical subgroups.
- IL-18 was upregulated in chronic progressive MS and relapsing MS patients in remission, but not during relapses.
- IL-1beta mRNA levels showed no significant alteration, with a possible decrease in chronic progression.
Conclusions:
- Elevated expression of caspase-1 and IL-18 suggests their involvement in the pathogenesis of multiple sclerosis.
- The increased IL-18 expression, potentially at the protein level, highlights a promising pathway for future therapeutic strategies in MS.
- Further research into the role of IL-18 and caspase-1 could lead to novel treatment approaches for multiple sclerosis.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Caspases
Inflammatory Bowel Disease III: Crohn's Disease
Multiple Sclerosis l: Introduction
